Alcoholism drug can 'wake up' dormant HIV to be killed, study finds

Will We Ever Cure HIV?

(Reuters) -- Scientists seeking a cure for the AIDS virus have made an unexpected discovery with a drug designed to combat alcoholism which they say could be a critical part of a strategy to "wake up" and then kill dormant HIV hiding in the body.

SEE ALSO: New York police shows muscle after Paris attacks

The drug, branded as Antabuse but also sold as a generic called disulfiram, was given to 30 HIV positive patients in America and Australia who were already taking antiretroviral therapy AIDS drugs.

At the highest given dose, there was evidence that "dormant HIV was activated", the researchers said in a study published in The Lancet HIV journal on Monday, and with no adverse effects.

Julian Elliott of the department of infectious diseases at The Alfred in Melbourne, Australia, who worked with Lewin, said waking up the virus was only the first step to eliminating it.

Notable people with HIV/AIDS:

Notable people with HIV/AIDS
See Gallery
Alcoholism drug can 'wake up' dormant HIV to be killed, study finds

American rapper Eazy-E

(Photo by Michael Ochs Archives/Getty Images)

American fashion designer Perry Ellis (1940 - 1986) at the Council of Fashion Designers of America 1981 awards dinner at the New York Public Library on 42nd Street, New York City, 14th January 1982. (Photo by Tom Gates/Archive Photos/Getty Images)

Photographer Robert Mapplethorpe

(Photo by Leee Black Childers/Redferns)


"The next step is to get these cells to die," he said.

HIV latency, where the virus remains dormant in the body in people taking ART, is one of the biggest hurdles to achieving a cure for the viral infection that causes AIDS.

HIV can be held in check by ART, and by the end of 2014 an estimated 36.9 million people around the world were living with the virus. Some 2 million people a year are newly infected.

Scientists say finding ways of "waking up" the virus in these dormant cells and then destroying them is a key cure strategy, but researchers have so far been unable to find the exact effective combination of drugs.

SEE ALSO: Sheriff: 6 dead in campsite attack; man charged with murder

Sharon Lewin, a University of Melbourne professor who led the work, said that while scientists have made headway into activating latent HIV, one of the main concerns is the toxicity of the drugs trailed.

With disulfiram, however, this did not appear to present a problem, she said.

"The dosage of disulfiram we used provided more of a tickle than a kick to the virus, but this could be enough. Even though the drug was only given for three days, we saw a clear increase in (the) virus in (the) plasma, which was very encouraging."

More from
Protests erupt after black man shot by police in Minneapolis
Some governors halt, question plan to accept Syrian refugees
Geraldo Rivera hugs daughter in Paris after attacks

Read Full Story

From Our Partners